Global Malignant Mesothelioma Therapeutics Market, 7% CAGR Projection Over the Next Five Years
LONDON–(BUSINESS WIRE)–#Biotechnology–The global malignant mesothelioma therapeutics market is expected to post a CAGR of close to 7% during the period…
Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#Biotechnology–The global malignant mesothelioma therapeutics market is expected to post a CAGR of close to 7% during the period…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global malignant mesothelioma therapeutics market is expected to post a CAGR of close to 7% during the period…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global motion sickness drugs market is expected to post a CAGR close to 4% during the period 2019-2023,…
SALISBURY, Md.–(BUSINESS WIRE)–Jubilant Cadista Pharmaceuticals Inc. is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
Opens office in Taipei, Taiwan SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#clinicalresearch—Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces the formal…
Opens office in Taipei, Taiwan SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#clinicalresearch—Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces the formal…
Strengthens and expands its OmniAb platform offering SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the signing of an agreement…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it has commenced an underwritten public offering of 6,000,000 shares…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board…